Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia

Clin Mol Hepatol. 2024 Mar 6. doi: 10.3350/cmh.2024.0157. Online ahead of print.

Authors

Hiroyuki Suzuki¹, Tsubasa Tsutsumi¹, Machiko Kawaguchi¹, Keisuke Amano¹, Takumi Kawaguchi¹

Affiliation

¹ Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.

PMID: 38447531
DOI: 10.3350/cmh.2024.0157

No abstract available

Keywords: Steatotic liver disease; atherosclerotic cardiovascular disease; metabolic; steatosis.